Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Daybrook Fisheries is a leading producer of high-quality fish meal and fish oil, specializing in the processing of Gulf Menhaden. Headquartered in Empire, Louisiana, the company operates a vertically integrated business model that includes its own fishing fleet and a state-of-the-art processing facility. Its fish oil is a primary source of essential Omega-3 fatty acids, specifically eicosapentaenoic acid and docosahexaenoic acid, which are supplied to the global nutraceutical and pharmaceutical markets. These products are critical components in cardiovascular health supplements and specialized medical diets. The company also serves the aquaculture and animal feed industries by providing high-protein nutritional ingredients. Since its acquisition by the Oceana Group in 2015, Daybrook has continued to expand its role as a key supplier in the global health and nutrition supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Daybrook Fisheries.